{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:17:29Z","timestamp":1770967049664,"version":"3.50.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002923","name":"Consejo Nacional de Investigaciones Cient\u00edficas y T\u00e9cnicas","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002923","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006668","name":"Fondo para la Investigaci\u00f3n Cient\u00edfica y Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.jinf.2020.05.052","type":"journal-article","created":{"date-parts":[[2020,5,28]],"date-time":"2020-05-28T18:05:52Z","timestamp":1590689152000},"page":"276-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis"],"prefix":"10.1016","volume":"81","author":[{"given":"Carlos J.","family":"Pirola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Silvia","family":"Sookoian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jinf.2020.05.052_bib0001","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.jinf.2020.05.052_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinf.2020.05.010","article-title":"Age but not sex may explain the negative effect of arterial hyptertension and diabetes on COVID-19 prognosis","author":"Pirola","year":"2020","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2020.05.052_bib0003","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area","author":"Richardson","year":"2020","journal-title":"JAMA"},{"issue":"10229","key":"10.1016\/j.jinf.2020.05.052_bib0004","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.jinf.2020.05.052_bib0005","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jinf.2020.05.052_bib0006","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-Angiotensin-Aldosterone System Blockers and the Risk of Covid-19","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.05.052_bib0007","article-title":"Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19","author":"Mehra","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.05.052_bib0008","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jinf.2020.05.052_bib0009","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2008975","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors and Risk of Covid-19","author":"Reynolds","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2020.05.052_bib0010","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan","author":"Li","year":"2020","journal-title":"China. JAMA Cardiol"},{"key":"10.1016\/j.jinf.2020.05.052_bib0011","article-title":"Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.jinf.2020.05.052_bib0012","article-title":"Hypertension and Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","author":"Ip","year":"2020","journal-title":"medRxiv preprint."},{"key":"10.1016\/j.jinf.2020.05.052_bib0013","article-title":"ACE-inhibitors and Angiotensin-2 Receptor Blockers are not associated with severe SARSCOVID19 infection in a multi-site UK acute Hospital Trust","author":"Bean","year":"2020","journal-title":"medRxiv."},{"key":"10.1016\/j.jinf.2020.05.052_bib0014","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15312","article-title":"RAAs inhibitors and outcome in patients with SARS-CoV-2 pneumonia. A case series study","author":"Conversano","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jinf.2020.05.052_bib0015","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.202002-0445OC","article-title":"COVID-19 with Different Severity: A Multi-center Study of Clinical Features","author":"Feng","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jinf.2020.05.052_bib0016","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jinf.2020.05.052_bib0017","article-title":"Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients","author":"Liu","year":"2020","journal-title":"medRxiv preprint."},{"issue":"1","key":"10.1016\/j.jinf.2020.05.052_bib0018","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.jinf.2020.05.052_bib0019","doi-asserted-by":"crossref","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study. YANG2020","author":"Yang","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.jinf.2020.05.052_bib0020","article-title":"Hypertension in patients hospitalized with COVID-19 in Wuhan, China: A single-center retrospective observational study","author":"Zeng","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.jinf.2020.05.052_bib0021","doi-asserted-by":"crossref","first-page":"7027","DOI":"10.1038\/srep07027","article-title":"Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury","volume":"4","author":"Yang","year":"2014","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.jinf.2020.05.052_bib0022","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jinf.2020.05.052_bib0023","doi-asserted-by":"crossref","DOI":"10.1002\/ddr.21656","article-title":"Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics","author":"Gurwitz","year":"2020","journal-title":"Drug Dev Res"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320303297?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163445320303297?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T21:29:34Z","timestamp":1759008574000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163445320303297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0163445320303297"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2020.05.052","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimation of Renin-Angiotensin-Aldosterone-System (RAAS)-Inhibitor effect on COVID-19 outcome: A Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2020.05.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The British Infection Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}